Phase 1b study of first-line Ramucirumab plus Platinum plus Fluoropyrimidine in Japanese Patients with advanced gastric cancer

被引：0
|
作者：
Kadowaki, Shigenori [1 ]
Shitara, Kohei [2 ]
Sakai, Daisuke [3 ]
Nishina, Tomohiro [4 ]
Yoshikawa, Reigetsu [5 ]
Piao, Yongzhe [5 ]
Ozeki, Akichika [5 ]
Inoue, Koichi [5 ]
Muro, Kei [1 ]
机构：
[1] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan
[2] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[3] Osaka Univ Hosp, Osaka, Japan
[4] Shikoku Canc Ctr, Matsuyama, Ehime, Japan
[5] Eli Lilly Japan KK, Kobe, Hyogo, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O3 - 9 - 4
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prognostic value of natural killer cell activity for patients with HER2+advanced gastric cancer treated with first-line fluoropyrimidine-platinum doublet plus trastuzumab
    Cho, Hyungwoo
    Ryu, Min-Hee
    Lee, Hyung Eun
    Kim, Hyung-Don
    Kang, Yoon-Koo
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (04) : 829 - 838
  • [42] Fluoropyrimidine (F) alone versus F plus platinum (P) as first-line chemotherapy in patients (pts) with advanced gastric cancer (AGC) and severe peritoneal metastasis (SPM): A multicenter observational study
    Arai, Hiroyuki
    Iwasa, Satoru
    Boku, Narikazu
    Kawahira, Masahiro
    Yasui, Hirofumi
    Masuishi, Toshiki
    Muro, Kei
    Hironaka, Shuichi
    Fukuda, Naoki
    Takahari, Daisuke
    Nakajima, Takako Eguchi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [43] Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxane
    Hironaga Satake
    Tamotsu Sagawa
    Koshi Fujikawa
    Yukimasa Hatachi
    Hisateru Yasui
    Masahito Kotaka
    Takeshi Kato
    Akihito Tsuji
    [J]. Cancer Chemotherapy and Pharmacology, 2018, 82 : 839 - 845
  • [44] Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxane
    Satake, Hironaga
    Sagawa, Tamotsu
    Fujikawa, Koshi
    Hatachi, Yukimasa
    Yasui, Hisateru
    Kotaka, Masahito
    Kato, Takeshi
    Tsuji, Akihito
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (05) : 839 - 845
  • [45] A phase 1/2 study of ramucirumab plus nivolumab in patients with previously treated advanced gastric adenocarcinoma
    Shoji, H.
    Miyamoto, H.
    Hara, H.
    Takahari, D.
    Machida, N.
    Esaki, T.
    Nagashima, K.
    Aoki, K.
    Honda, K.
    Nagata, Y.
    Miyamoto, T.
    Boku, N.
    Kato, K.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [46] A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric Cancer
    LaBonte, Melissa J.
    Yang, Dongyun
    Zhang, Wu
    Wilson, Peter M.
    Nagarwala, Yasir M.
    Koch, Kevin M.
    Briner, Colleen
    Kaneko, Tomomi
    Rha, Sun-Young
    Gladkov, Oleg
    Urba, Susan G.
    Sakaeva, Dina
    Pishvaian, Michael J.
    Hsieh, Ruey-Kuen
    Lee, Wei-Ping
    Lenz, Heinz-Josef
    [J]. MOLECULAR CANCER THERAPEUTICS, 2016, 15 (09) : 2251 - 2258
  • [47] Clinical Study of S-1 Plus Oxaliplatin Versus S-1 Plus Cisplatin as First-Line Treatment for Elderly Patients with Advanced Gastric Cancer
    Bo Deng-feng
    Hu Xiu-fu
    [J]. JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2015, 3 (04): : 238 - 242
  • [48] First-line sunitinib plus FOLFIRI in Japanese patients with unresectable/metastatic colorectal cancer: A phase II study
    Tsuji, Yasushi
    Satoh, Taroh
    Tsuji, Akihito
    Muro, Kei
    Yoshida, Motoki
    Nishina, Tomohiro
    Nagase, Michitaka
    Komatsu, Yoshito
    Kato, Takeshi
    Miyata, Yoshinori
    Mizutani, Naoko
    Hashigaki, Satoshi
    Lechuga, Maria Jose
    Denda, Tadamichi
    [J]. CANCER SCIENCE, 2012, 103 (08) : 1502 - 1507
  • [49] Phase II study of S-1 plus docetaxel as first-line treatment for elderly patients with advanced gastric cancer (OGSG0902).
    Matsuyama, Jin
    Imamura, Hiroshi
    Kawabata, Ryohei
    Kawase, Tomono
    Okada, Kazuyuki
    Nishikawa, Kazuhiro
    Kurokawa, Yukinori
    Fujitani, Kazumasa
    Shimokawa, Toshio
    Satoh, Taroh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [50] A multi-center phase II study of S-1 plus paclitaxel as first-line therapy in patients with advanced or relapsed gastric cancer
    Lee, J. J.
    Kim, S. Y.
    Chung, H. C.
    Lee, K. H.
    Song, H. S.
    Woo, I. S.
    Hong, Y. S.
    Kang, W. K.
    Choi, J. H.
    Choi, I. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345